{"id":"https://openalex.org/W4291018893","doi":"https://doi.org/10.3389/fphar.2022.974921","title":"Editorial: Biomedical advances in ultrasound-mediated drug/molecule delivery","display_name":"Editorial: Biomedical advances in ultrasound-mediated drug/molecule delivery","publication_year":2022,"publication_date":"2022-08-11","ids":{"openalex":"https://openalex.org/W4291018893","doi":"https://doi.org/10.3389/fphar.2022.974921","pmid":"https://pubmed.ncbi.nlm.nih.gov/36034831","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9404323"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2022.974921","doi":"https://doi.org/10.3389/fphar.2022.974921","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2022.974921","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2022.974921/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"editorial","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fphar.2022.974921/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066766358","display_name":"Agata A. Exner","orcid":"https://orcid.org/0000-0003-3913-7066","observed_orcids":["https://orcid.org/0000-0003-3913-7066"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Agata A. Exner","raw_affiliation_strings":["Case Western Reserve University, Cleveland, OH, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Western Reserve University, Cleveland, OH, United States","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038946277","display_name":"Jean\u2010Michel Escoffre","orcid":"https://orcid.org/0000-0003-1041-6950","observed_orcids":["https://orcid.org/0000-0003-1041-6950"]},"institutions":[{"id":"https://openalex.org/I110017253","display_name":"Universit\u00e9 de Tours","ror":"https://ror.org/02wwzvj46","country_code":"FR","type":"education","lineage":["https://openalex.org/I110017253"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210093987","display_name":"Imaging, Brain, and Neuropsychiatry","ror":"https://ror.org/01eem7c55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I110017253","https://openalex.org/I154526488","https://openalex.org/I4210093987"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Jean-Michel Escoffre","raw_affiliation_strings":["UMR 1253, iBrain, Universit\u00e9 de Tours, Inserm, Tours, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UMR 1253, iBrain, Universit\u00e9 de Tours, Inserm, Tours, France","institution_ids":["https://openalex.org/I110017253","https://openalex.org/I154526488","https://openalex.org/I4210093987"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5038946277"],"corresponding_institution_ids":["https://openalex.org/I110017253","https://openalex.org/I154526488","https://openalex.org/I4210093987"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":null,"first_page":"974921","last_page":"974921"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10958","display_name":"Ultrasound and Hyperthermia Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10958","display_name":"Ultrasound and Hyperthermia Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12015","display_name":"Photoacoustic and Ultrasonic Imaging","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ultrasound-mediated-drug-delivery","display_name":"ultrasound-mediated drug delivery","score":0.9850000143051147},{"id":"https://openalex.org/keywords/therapeutic-ultrasound","display_name":"ultrasound therapy","score":0.7870000004768372},{"id":"https://openalex.org/keywords/microbubbles","display_name":"microbubbles","score":0.906000018119812},{"id":"https://openalex.org/keywords/biological-barriers","display_name":"biological barriers","score":0.7080000042915344},{"id":"https://openalex.org/keywords/drug-biodistribution","display_name":"drug biodistribution","score":0.6740000247955322},{"id":"https://openalex.org/keywords/gene-delivery","display_name":"gene delivery","score":0.7540000081062317},{"id":"https://openalex.org/keywords/translation-gaps","display_name":"translation gaps","score":0.5220000147819519},{"id":"https://openalex.org/keywords/preclinical-to-clinical-translation","display_name":"preclinical to clinical translation","score":0.7279999852180481},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.6190000176429749}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5658913254737854},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5434809327125549},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.4887557029724121},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.47232598066329956},{"id":"https://openalex.org/C162264550","wikidata":"https://www.wikidata.org/wiki/Q17112037","display_name":"Translational medicine","level":2,"score":0.4209647476673126},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.31720131635665894},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1149420440196991},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fphar.2022.974921","doi":"https://doi.org/10.3389/fphar.2022.974921","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2022.974921","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2022.974921/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9404323","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9404323","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:36034831","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36034831","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Editorial"},{"id":"pmh:oai:HAL:inserm-03749549v1","doi":null,"is_oa":true,"landing_page_url":"https://inserm.hal.science/inserm-03749549","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"2022, ⟨10.3389/fphar.2022.974921⟩","raw_type":"info:eu-repo/semantics/other"},{"id":"pmh:oai:doaj.org/article:48ca4a5a482d4ef098504deb063ddd0f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/48ca4a5a482d4ef098504deb063ddd0f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 13 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2022.974921","doi":"https://doi.org/10.3389/fphar.2022.974921","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2022.974921","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2022.974921/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4291018893.pdf","grobid_xml":"https://content.openalex.org/works/W4291018893.grobid-xml"},"referenced_works_count":5,"referenced_works":["https://openalex.org/W1513992389","https://openalex.org/W2106925111","https://openalex.org/W2111808019","https://openalex.org/W2132718476","https://openalex.org/W3159034163"],"related_works":["https://openalex.org/W3134297015","https://openalex.org/W4408185668","https://openalex.org/W4392343799","https://openalex.org/W2124247288","https://openalex.org/W1973812206","https://openalex.org/W2143195637","https://openalex.org/W2593699820","https://openalex.org/W2123285370","https://openalex.org/W2078957473","https://openalex.org/W3021205097"],"abstract_inverted_index":{"Editorial":[0],"on":[1,161],"the":[2,11,18,44,49,80,108,117,162,166,209,222,229,248],"Research":[3],"Topic":[4],"Biomedical":[5],"advances":[6,25,216],"in":[7,54,73,96,127,138,190,196,221,225],"ultrasound-mediated":[8],"drug/molecule":[9,206],"deliveryDespite":[10],"increasing":[12],"number":[13],"of":[14,20,43,51,82,86,110,119,124,134,164,180,212,247,250,264],"innovative":[15],"drugs":[16],"and":[17,31,38,59,103,114,140,193,199,202,271,280],"development":[19],"novel":[21],"targeted":[22],"methods,":[23],"therapeutic":[24,46,87,104,112,121,146],"remain":[26],"modest":[27],"for":[28],"many":[29,120,226],"prevalent":[30],"costly":[32],"diseases":[33,40],"including":[34],"neurodegenerative":[35],"disorders,":[36],"cancers,":[37],"cardiovascular":[39],"among":[41],"others.One":[42],"major":[45,135],"hurdles":[47],"is":[48,130,241,259],"presence":[50],"biological":[52,125,181],"barriers":[53,77,126,182],"multiple":[55],"organs":[56],"(e.g.,":[57,89],"endothelial":[58],"epithelial":[60],"barriers,":[61],"plasma":[62],"membrane,":[63],"interstitial":[64],"pressure,":[65],"detoxification":[66],"processes,":[67],"etc.).While":[68],"they":[69],"sustain":[70],"organ/tissue":[71],"homeostasis":[72],"physiological":[74],"conditions,":[75],"these":[76,215],"substantially":[78],"impede":[79],"delivery":[81,152],"a":[83,132,191,218,242,255],"vast":[84],"majority":[85],"molecules":[88,113],"chemotherapeutics,":[90],"antibiotics,":[91],"nucleic":[92],"acids,":[93],"antibodies,":[94],"etc.)":[95],"diseased":[97],"tissues,":[98],"thus":[99],"reducing":[100],"their":[101],"bioavailability":[102],"effect.This":[105],"challenge":[106],"narrows":[107],"landscape":[109],"usable":[111],"drastically":[115],"influences":[116],"design":[118,279],"protocols.Therefore,":[122],"crossing":[123,179],"drug":[128],"studies":[129,273],"undoubtedly":[131],"source":[133],"RD":[136],"investments":[137],"academia":[139],"pharmaceutical":[141],"industry.For":[142],"over":[143],"2":[144],"decades,":[145],"ultrasound":[147],"(US)":[148],"applications":[149],"facilitating":[150],"gene/drug":[151],"have":[153],"been":[154,184],"widely":[155],"investigated,":[156],"with":[157],"some":[158],"approaches":[159],"being":[160],"brink":[163],"reaching":[165],"bedside.Among":[167],"these,":[168],"using":[169],"US-responsive":[170],"particles":[171],"injected":[172],"systemically,":[173],"e.g.,":[174],"microbubbles,":[175],"to":[176,234,261],"facilitate":[177],"US-mediated,":[178],"has":[183],"shown":[185],"to:":[186],"1)":[187],"be":[188],"applicable":[189],"standardized":[192],"non-invasive":[194],"fashion":[195],"laboratory":[197],"animals":[198],"human":[200],"subjects,":[201],"2)":[203],"render":[204],"therapeutically-achievable":[205],"biodistribution,":[207],"supporting":[208],"clinical":[210,252,256,265,277],"translatability":[211],"this":[213],"modality.While":[214],"foresee":[217],"\"blue":[219],"sky\"":[220],"field,":[223],"like":[224],"medical":[227],"specialties,":[228],"translation":[230],"gap":[231],"remains":[232],"challenging":[233],"evaluate.One":[235],"may":[236],"ask":[237],"-to":[238],"what":[239],"extent":[240],"successful":[243],"pre-clinical":[244],"study":[245],"predictive":[246],"outcome":[249],"its":[251],"counterpart?Before":[253],"devising":[254],"study,":[257],"it":[258],"essential":[260],"boost":[262],"chances":[263],"success":[266],"by":[267],"conducting":[268],"impactful":[269],"in-vitro":[270],"preclinical":[272],"that":[274],"can":[275],"inform":[276],"trial":[278],"enable":[281],"technology":[282],"translation.":[283]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2022-08-13T00:00:00"}